463
Participants
Start Date
April 14, 2016
Primary Completion Date
May 31, 2018
Study Completion Date
December 20, 2018
Insulin glargine,300 U/mL
Subcutaneous injection in the morning or evening using a prefilled pen. Dose titration to achieve fasting self-monitored plasma glucose (SMPG) from 90 to 130 milligram/deciliter (mg/dL) (5.0 to 7.2 millimol per liter \[mmol/L\])
Insulin glargine (100 units /mL)
Subcutaneous injection in the morning or evening using a prefilled pen. Dose titration to achieve fasting SMPG from 90 to 130 mg/dL (5.0 to 7.2 mmol/L)
Background therapy
Fast-acting mealtime insulin analogs
Investigational Site Number 8070001, Skopje
Investigational Site Number 3480001, Budapest
Investigational Site Number 3480004, Budapest
Investigational Site Number 3480003, Budapest
Investigational Site Number 1000005, Sofia
Investigational Site Number 2080001, Herlev
Investigational Site Number 3480002, Miskolc
Investigational Site Number 1000001, Plovdiv
Investigational Site Number 0320007, San Miguel de Tucumán
Investigational Site Number 0320005, Salta
Investigational Site Number 0320006, Mendoza
Investigational Site Number 3480005, Gyula
Investigational Site Number 3480006, Pécs
Investigational Site Number 3480007, Székesfehérvár
Investigational Site Number 1000004, Varna
Investigational Site Number 3800004, Torino
Investigational Site Number 6880002, Belgrade
Investigational Site Number 6880003, Belgrade
Investigational Site Number 8400015, Buffalo
Investigational Site Number 2030001, Praha 5 - Motol
Investigational Site Number 6880004, Niš
Investigational Site Number 8400030, Philadelphia
Investigational Site Number 3800006, Varese
Investigational Site Number 8400035, Morehead City
Investigational Site Number 2760002, Hanover
Investigational Site Number 8400037, Atlanta
Investigational Site Number 2500002, Toulouse
Investigational Site Number 3760001, Haifa
Investigational Site Number 4840003, Durango
Investigational Site Number 2500003, Montpellier
Investigational Site Number 3800003, Verona
Investigational Site Number 7240006, Santa Cruz de Tenerife
Investigational Site Number 8400032, Indianapolis
Investigational Site Number 2760003, Münster
Investigational Site Number 3800001, Florence
Investigational Site Number 8400010, Rapid City
Investigational Site Number 3760006, Holon
Investigational Site Number 4840001, Monterrey
Investigational Site Number 2760001, Heidelberg
Investigational Site Number 2030005, Ostrava - Poruba
Investigational Site Number 4840002, Puebla City
Investigational Site Number 8400038, Oklahoma City
Investigational Site Number 8400005, Dallas
Investigational Site Number 8400021, Dallas
Investigational Site Number 8400029, Lufkin
Investigational Site Number 3760003, Beersheba
Investigational Site Number 8400008, Tucson
Investigational Site Number 4840005, Veracruz
Investigational Site Number 8400034, Seattle
Investigational Site Number 6430001, Moscow
Investigational Site Number 6430002, Saint Petersburg
Investigational Site Number 6420004, Craiova
Investigational Site Number 6430004, Smolensk
Investigational Site Number 6420003, Timișoara
Investigational Site Number 6430003, Ufa
Investigational Site Number 6420006, Sibiu
Investigational Site Number 6420007, Constanța
Investigational Site Number 1520007, Temuco
Investigational Site Number 1520002, Santiago
Investigational Site Number 1520004, Santiago
Investigational Site Number 8400016, Chapel Hill
Investigational Site Number 0320003, Caba
Investigational Site Number 0320001, Caba
Investigational Site Number 0320004, Capital Federal
Investigational Site Number 0320002, Capital Federal
Investigational Site Number 0760005, Curitiba
Investigational Site Number 0760006, Fortaleza
Investigational Site Number 0760004, Fortaleza
Investigational Site Number 0760003, Porto Alegre
Investigational Site Number 0760001, São Paulo
Investigational Site Number 0760002, São Paulo
Investigational Site Number 1520006, Santiago
Investigational Site Number 1520003, Viña del Mar
Investigational Site Number 3760002, Petah Tikva
Investigational Site Number 3920006, Chiyoda-Ku
Investigational Site Number 3920002, Fukuoka
Investigational Site Number 3920003, Hiroshima
Investigational Site Number 3920007, Kobe
Investigational Site Number 3920005, Osaka
Investigational Site Number 3920004, Shinjuku-Ku
Investigational Site Number 1240003, Halifax
Investigational Site Number 1240002, Montreal
Investigational Site Number 1240005, Montreal
Investigational Site Number 1240006, Sherbrooke
Investigational Site Number 2030003, Hradec Králové
Investigational Site Number 2760004, Leipzig
Investigational Site Number 3800005, Roma
Investigational Site Number 4280002, Daugavpils
Investigational Site Number 4280001, Riga
Investigational Site Number 4840004, México
Investigational Site Number 6160005, Bielsko-Biala
Investigational Site Number 6160001, Gdansk
Investigational Site Number 6160006, Szczecin
Investigational Site Number 6160007, Warsaw
Investigational Site Number 6160004, Warsaw
Investigational Site Number 6160003, Warsaw
Investigational Site Number 6420005, Bucharest
Investigational Site Number 7240005, Barcelona
Investigational Site Number 7240002, Barcelona
Investigational Site Number 7240003, Esplugues de Llobregat
Investigational Site Number 7240004, Sabadell
Investigational Site Number 7240001, Vitoria-Gasteiz
Investigational Site Number 7520002, Stockholm
Investigational Site Number 8260005, Doncaster
Investigational Site Number 8260001, Ipswich
Investigational Site Number 8260004, Kettering
Investigational Site Number 8260002, Salisbury
Lead Sponsor
Sanofi
INDUSTRY